Knockdown lncRNA CRNDE enhances temozolomide chemosensitivity by regulating autophagy in glioblastoma

被引:0
|
作者
Zijin Zhao
Miaomiao Liu
Wenyong Long
Jian Yuan
Haoyu Li
Chi Zhang
Guodong Tang
Weixi Jiang
Xianrui Yuan
Minghua Wu
Qing Liu
机构
[1] Xiangya Hospital,Department of Neurosurgery
[2] Central South University,Department of Nuclear Medicine (PET
[3] Neurosurgical Medical Central,CT Central)
[4] Central South University,The Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education
[5] Clinical Research Center For Skull Base Surgery and Neuro-Oncology In Hunan Province,undefined
[6] Xiangya Hospital,undefined
[7] Central South University,undefined
[8] Cancer Research Institute,undefined
[9] Central South University,undefined
来源
关键词
CRNDE; Glioblastoma multiforme; Temozolomide; Chemosensitivity; Autophagy; PI3K/Akt/mTOR;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Knockdown lncRNA CRNDE enhances temozolomide chemosensitivity by regulating autophagy in glioblastoma
    Zhao, Zijin
    Liu, Miaomiao
    Long, Wenyong
    Yuan, Jian
    Li, Haoyu
    Zhang, Chi
    Tang, Guodong
    Jiang, Weixi
    Yuan, Xianrui
    Wu, Minghua
    Liu, Qing
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [2] Knockdown lncRNA DLEU1 Inhibits Gliomas Progression and Promotes Temozolomide Chemosensitivity by Regulating Autophagy
    Lv, Qiao-Li
    Wang, Li-Chong
    Li, Dang-Chi
    Lin, Qian-Xia
    Shen, Xiao-Li
    Liu, Hai-Yun
    Li, Min
    Ji, Yu-Long
    Qin, Chong-Zhen
    Chen, Shu-Hui
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [3] Knockdown of lncRNA-XIST enhances the chemosensitivity of NSCLC cells via suppression of autophagy
    Sun, Wei
    Zu, Yukun
    Fu, Xiangning
    Deng, Yu
    ONCOLOGY REPORTS, 2017, 38 (06) : 3347 - 3354
  • [4] Knockdown of CDC2 expression inhibits proliferation, enhances apoptosis, and increases chemosensitivity to temozolomide in glioblastoma cells
    Zhou, Baosheng
    Bu, Guoyun
    Zhou, Yipin
    Zhao, Yue
    Li, Wei
    Li, Mu
    MEDICAL ONCOLOGY, 2015, 32 (01)
  • [5] Knockdown of CDC2 expression inhibits proliferation, enhances apoptosis, and increases chemosensitivity to temozolomide in glioblastoma cells
    Baosheng Zhou
    Guoyun Bu
    Yipin Zhou
    Yue Zhao
    Wei Li
    Mu Li
    Medical Oncology, 2015, 32
  • [6] Inhibition of Aurora kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells
    Kleiton Silva Borges
    Angel Maurício Castro-Gamero
    Daniel Antunes Moreno
    Vanessa da Silva Silveira
    Maria Sol Brassesco
    Rosane Gomes de Paula Queiroz
    Harley Francisco de Oliveira
    Carlos Gilberto Carlotti
    Carlos Alberto Scrideli
    Luiz Gonzaga Tone
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 405 - 414
  • [7] Inhibition of Aurora kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells
    Borges, Kleiton Silva
    Castro-Gamero, Angel Mauricio
    Moreno, Daniel Antunes
    Silveira, Vanessa da Silva
    Brassesco, Maria Sol
    de Paula Queiroz, Rosane Gomes
    de Oliveira, Harley Francisco
    Carlotti, Carlos Gilberto, Jr.
    Scrideli, Carlos Alberto
    Tone, Luiz Gonzaga
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (03) : 405 - 414
  • [8] CHLOROQUINE ENHANCES THE CYTOTOXIC EFFECTS OF TEMOZOLOMIDE IN GLIOBLASTOMA CELLS BY BLOCKING AUTOPHAGY
    Golden, Encouse B.
    Cho, Hee-Yeon
    Louie, Stan G.
    Hofman, Florence M.
    Schonthal, Axel
    Chen, Thomas C.
    NEURO-ONCOLOGY, 2009, 11 (05) : 587 - 587
  • [9] Knockdown of STMN1 enhances osteosarcoma cell chemosensitivity through inhibition of autophagy
    Wang, Zili
    He, Rongzhen
    Xia, Hansong
    Wei, Yu
    Wu, Song
    ONCOLOGY LETTERS, 2017, 13 (05) : 3465 - 3470
  • [10] Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma
    Zeng, Ailiang
    Wei, Zhiyun
    Yan, Wei
    Yin, Jianxing
    Huang, Xiaoxu
    Zhou, Xu
    Li, Rui
    Shen, Feng
    Wu, Weining
    Wang, Xiefeng
    You, Yongping
    CANCER LETTERS, 2018, 436 : 10 - 21